Detailed view for PVX_089305

Basic information

TDR Targets ID: 268155
Plasmodium vivax, protein kinase, putative

Source Database / ID:  PlasmoDB 

pI: 7.9293 | Length (AA): 800 | MW (Da): 89649 | Paralog Number: 0

Signal peptide: N | GPI Anchor: N | Predicted trans-membrane segments: 0

Druggability Group : DG5

Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable

Pfam domains

PF00069   Protein kinase domain

Gene Ontology

Mouse over links to read term descriptions.
GO:0004674   protein serine/threonine kinase activity  
GO:0004672   protein kinase activity  
GO:0005524   ATP binding  
GO:0004713   protein tyrosine kinase activity  
GO:0006468   protein amino acid phosphorylation  

Metabolic Pathways

This gene is not mapped to any metabolic pathway in KEGG.

Structural information

Modbase 3D models:

There are 12 models calculated for this protein. More info on these models, including the models themselves is available at: Modbase

Target Beg Target End Template Template Beg Template End Identity Evalue Model Score MPQS zDope
34 123 2a19 (B) 266 377 22.00 0.0000011 0.15 0.34 -0.09
429 770 1j1b (A) 46 383 27.00 0 1 0.65 0.25
597 719 1ob3 (A) 164 286 38.00 0 0.97 0.63 -0.95
29 111 4mvf (A) 64 147 46.00 0.0000048 0.92 0.45095 0.35
32 96 4equ (B) 33 101 34.00 0.16 0.98 0.28945 2
573 721 4rlk (A) 171 328 37.00 0 1 0.53345 -0.17
573 753 4dit (A) 196 367 46.00 0 0.95 0.47845 0.83
573 656 3kvw (A) 291 371 43.00 0.0000000043 0.4 0.4352 0.6
576 770 1j1b (A) 199 383 41.00 0 1 0.63545 0.14
592 720 3niz (A) 178 307 41.00 0 0.99 0.63095 -0.35
593 722 4yno (A) 182 313 38.00 0 0.84 0.6037 -0.37
596 718 2i6l (A) 194 317 31.00 0.000000072 0.83 0.56545 -0.93

Help me make sense of these data.

Target Beg: first modeled residue
Target End: last modeled residue
Template: template structure used for modelling (PDB accession and chain)
Template Beg: first template residue in target-template alignment
Template End: last template residue in target-template alignment
Identity: sequence identity
Evalue: E value for target-template hit
Model Score: GA341 score (>0.7 for reliable model)
MPQS: ModPipe Quality Score (>1.1 for reliable model)
zDope: zDope Score (negative for reliable model)

A more detailed description of these scores is available at the Modbase Model Evaluation Help Pages, and in the papers referenced therein.

PDB Structures:

No structure availble in the PDB for this protein

Expression

Upregulation Percent Ranking Stage Dataset
Upper 60-80% percentile intraerythrocytic - 6 hs, intraerythrocytic - 30 hs, intraerythrocytic - 36 hs, intraerythrocytic - 40 hs, intraerythrocytic - 48 hs. Zhu L
Upregulation Percent Ranking Stage Dataset
Mid 40-60% percentile intraerythrocytic - 12 hs, intraerythrocytic - 18 hs, intraerythrocytic - 24 hs. Zhu L
Show/Hide expression data references
  • Zhu L New insights into the Plasmodium vivax transcriptome using RNA-Seq.

Orthologs

Ortholog group members (OG5_167106)

Species Accession Gene Product
Plasmodium berghei PBANKA_0709700   protein kinase 1
Plasmodium falciparum PF3D7_0821100   protein kinase 1
Plasmodium knowlesi PKNH_1315100   protein kinase 1, putative
Plasmodium vivax PVX_089305   protein kinase, putative
Plasmodium yoelii PY05890   protein kinase-related

Essentiality

No essentiality data collected for this gene and/or its orthologs.

Phenotypes and Validation (curated)

We have no manually annotated phenotypes for this target. What does this mean? / Care to help?

In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.

In any case, if you have information about papers containing relevant validation data for this target, please contact us.


Annotated validation

No validation data for this target

Associated compounds / Druggability

Druggability index (range: 0 to 1): 0.1


Known modulators for this target

No chemical compounds associated to this gene

Predicted associations

By orthology with druggable targets
Non orthologous druggable targets
By sequence similarity to non orthologous druggable targets
No additional associated druggable targets

Obtained from network model

Ranking Plot


Putative Drugs List


Compound Raw Global Species
0.0064 0.3377 0.5
0.0022 0.5 0.5
0.0059 1 1
0.0063 0.7244 0.7244
0.0093 0.8828 0
0.0032 0.5 0.5
0.0056 1 0.5
0.0088 0.4477 0.5
0.0081 1 0.5
0.0012 0.5 0.5
0.0003 0.5 0.5
0.0012 0.5 0.5
0.0037 1 0.5
0.0039 0.5 0.5
0.0032 0.5 0.5
0.0007 0.5 0.5
0.0016 0.5 0.5
0.0033 1 1
0.0012 0.5 0.5
0.0007 0.5 0.5
0.0081 0.5 0.5
0.0091 1 0.5
0.0004 0.5 0.5
0.0063 1 1
0.0033 0.5 0.5
0.0059 1 1
0.0069 0.3067 1
0.0018 0.5 0.5
0.0042 0.5 0.5
0.0061 0.6883 1
0.0039 0.5 0.5
0.0036 0.5 0.5
0.0026 0.5 0.5
0.0066 0.3101 0.5
0.0067 0.5 0.5
0.0016 0.5 0.5
0.0027 1 0.5
0.0059 1 1
0.0062 0.6935 0.5
0.0092 1 0.5
0.0029 0.5 0.5
0.0011 1 0.5
0.0008 0.5 0.5
0.0039 0.9485 0.5
0.0098 0.3242 0.2614
0.0023 0.5 0.5
0.0007 0.5 0.5

Assayability

Assay information

No assay information for this target.

Reagent availability

No reagent availability information for this target.

Bibliographic References

No literature references available for this target.

If you have references for this gene, please enter them in a user comment (below) or Contact us.

User comments

No user comments are available for this gene. Log in to add comments, or register.

Enter your comment

User ()
Gene identifier PVX_089305 (Plasmodium vivax), protein kinase, putative
Title for this comment
Comment